# Dartmouth Institute for Health Policy and Clinical Practice

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/dartmouth-institute-for-health-policy-and-clinical-practice/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 105 |
| Citations | 453,241 |
| City | Lebanon |
| Country | US |
| Description | Dartmouth Institute for Health Policy and Clinical Practice is a research organisation in Lebanon, US. OpenAlex records 5,400 works and 453,241 citations for it. 799 researchers list it as their most recent affiliation. |
| Homepage | http://tdi.dartmouth.edu/ |
| OpenAlex ID | https://openalex.org/I126688049 |
| Region | New Hampshire |
| Researchers | 799 |
| ROR ID | https://ror.org/0511yej17 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q7729073 |
| Works | 5,400 |

## University papers

- [Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline](https://scholariq.org/papers/management-of-immune-related-adverse-events-in-patients-treated-with-immune/)
- [Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.](https://scholariq.org/papers/interferon-alfa-2b-adjuvant-therapy-of-high-risk-resected-cutaneous-melanoma-the/)
- [High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190](https://scholariq.org/papers/high-and-low-dose-interferon-alfa-2b-in-high-risk-melanoma-first-analysis-of/)
- [Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events](https://scholariq.org/papers/society-for-immunotherapy-of-cancer-sitc-clinical-practice-guideline-on-immune/)
- [Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/management-of-immunotherapy-related-toxicities-version-1-2019-nccn-clinical/)
- [Trends in the United States in the Treatment of Distal Radial Fractures in the Elderly](https://scholariq.org/papers/trends-in-the-united-states-in-the-treatment-of-distal-radial-fractures-in-the/)
- [NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-management-of-immunotherapy-related-toxicities-version/)
- [Laparoscopic Skills Are Improved With LapMentor??? Training](https://scholariq.org/papers/laparoscopic-skills-are-improved-with-lapmentor-training/)

## University top topics

Showing 8 of 25.

- [Healthcare Policy and Management](https://scholariq.org/topics/healthcare-policy-and-management/)
- [Primary Care and Health Outcomes](https://scholariq.org/topics/primary-care-and-health-outcomes/)
- [Patient-Provider Communication in Healthcare](https://scholariq.org/topics/patient-provider-communication-in-healthcare/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)
- [Palliative Care and End-of-Life Issues](https://scholariq.org/topics/palliative-care-and-end-of-life-issues/)
- [Healthcare cost, quality, practices](https://scholariq.org/topics/healthcare-cost-quality-practices/)
- [Health Policy Implementation Science](https://scholariq.org/topics/health-policy-implementation-science/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.